Sebastian Drube

Dr. Sebastian Drube

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 April 2024 in The FASEB Journal
Verified
Journal Article
Open access
MRMiriam Ringleb
Miriam Ringleb
FJFlorian Javelle
Florian Javelle
SHSimon Haunhorst
Simon Haunhorst
WBWilhelm Bloch
Wilhelm Bloch
LFLena Fennen
Lena Fennen
CPChristian Puta
Christian Puta
Myokines, released from the muscle, enable communication between the working muscles and other tissues. Their release during physical exercise is assumed to depend on immune–hormonal–metabolic interactions concerning mode (endurance or resistance exercise), duration, and intensity. This meta‐analysis aims to examine the acute changes of circulating myokines inducing immunoregulatory effects caused by a bout of resistance exercise and to consider potential moderators of the results. Based on this selection strategy, a systematic literature search was conducted for resistance exercise intervention studies measuring interleukin (IL‐) 6, IL‐10, IL‐1ra, tumor necrosis factor (TNF‐) α, IL‐15, IL‐7, transforming growth factor (TGF‐) β1, and fractalkines (FKN) before and immediately after resistance exercise in healthy individuals. Random‐effects meta‐analysis was performed for each myokine. We identified a moderate positive effect of resistance exercise for IL‐6 and IL‐1ra. Regarding IL‐15 and TNF‐α, small to moderate effects were found. For IL‐10, no significant effect was observed. Due to no data, meta‐analyses for IL‐7, TGF‐β1, and FKN could not be performed. No moderators (training status, type of exercise, risk of bias, age, sex, time of day, exercise volume, exercise intensity, exercise dose) of the results were detected for all tested myokines. Taken together, this systematic review and meta‐analysis showed immediate positive effects of an acute resistance exercise session on IL‐6, IL‐1ra, TNF‐α, and IL‐15 levels.

1 November 2016 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SDSebastian Drube
Sebastian Drube
FKFlorian Kraft
Florian Kraft
JDJan Dudeck
Jan Dudeck
AMAnna-Lena Müller
Anna-Lena Müller
FWFranziska Weber
Franziska Weber
TKThomas Kamradt
Thomas Kamradt
The IL-1R family member IL-33R mediates Fcε-receptor-I (FcεRI)-independent activation of mast cells leading to NF-κB activation and consequently the production of cytokines. IL-33 also induces the activation of MAPKs, such as p38. We aimed to define the relevance of the p38-targets, the MAPK-activated protein kinases 2 and 3 (MK2 and MK3) in IL-33-induced signaling and the resulting mast cell effector functions in vitro and in vivo. We demonstrate that the IL-33-induced IL-6 and IL-13 production strongly depends on the MK2/3-mediated activation of ERK1/2 and PI3K signaling. Furthermore, in the presence of the stem cell factors, IL-33 did induce an MK2/3-, ERK1/2- and PI3K-dependent production of TNF-α. In vivo, the loss of MK2/3 in mast cells decreased the IL-33-induced leukocyte recruitment and the resulting skin inflammation. Therefore, the MK2/3-dependent signaling in mast cells is essential to mediate IL-33-induced inflammatory responses. Thus, MK2/3 are potential therapeutic targets for suppression of IL-33-induced inflammation skin diseases such as psoriasis.

1 February 2018 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
CGChristiane Göpfert
Christiane Göpfert
NANico Andreas
Nico Andreas
FWFranziska Weber
Franziska Weber
NHNorman Häfner
Norman Häfner
TYTatiana Yakovleva
Tatiana Yakovleva
SDSebastian Drube
Sebastian Drube
IL-33 is an IL-1 cytokine superfamily member. Binding of IL-33 to the IL-33R induces activation of the canonical NF-κB signaling and activation of MAPKs. In bone marrow–derived dendritic cells, IL-33 induces the production of IL-6, IL-13, and TNF-α. However, the signaling pathways resulting in IL-33–induced effector functions of dendritic cells are unknown. In this article, we show that the IL-33–induced cytokine production is only partly dependent on p65. Thereby, p65 mediates the production of IL-6, but not of IL-13, whereas the p38–Mapk-activated protein kinases 2/3 (MK2/3) signaling module mediates the IL-13, but not the IL-6, production. In addition, GM-CSF, which is critical for the differentiation and proliferation of bone marrow–derived dendritic cells, potentiates the p65-dependent IL-6 and the p38-MK2/3–dependent IL-13 production. Furthermore, we found that effective TNF-α production is only induced in the presence of GM-CSF and IL-33 via the p38-MK2/3 signaling module. Taken together, we found that the p38-MK2/3 signaling module is essential to mediate IL-33–induced cytokine production in dendritic cells.

30 June 2021 in Immunology
Verified
Journal Article
Open access
PDF file
Paul Mike JordanPaul Mike Jordan
Paul Mike Jordan
NANico Andreas
Nico Andreas
MGMarco Groth
Marco Groth
PWPhiline Wegner
Philine Wegner
FWFranziska Weber
Franziska Weber
SDSebastian Drube
Sebastian Drube
IL‐33 and ATP are alarmins, which are released upon damage of cellular barriers or are actively secreted upon cell stress. Due to high‐density expression of the IL‐33 receptor T1/ST2 (IL‐33R), and the ATP receptor P2X7, mast cells (MCs) are one of the first highly sensitive sentinels recognizing released IL‐33 or ATP in damaged peripheral tissues. Whereas IL‐33 induces the MyD88‐dependent activation of the TAK1‐IKK2‐NF‐κB signalling, ATP induces the Ca2+‐dependent activation of NFAT. Thereby, each signal alone only induces a moderate production of pro‐inflammatory cytokines and lipid mediators (LMs). However, MCs, which simultaneously sense (co‐sensing) IL‐33 and ATP, display an enhanced and prolonged activation of the TAK1‐IKK2‐NF‐κB signalling pathway. This resulted in a massive production of pro‐inflammatory cytokines such as IL‐2, IL‐4, IL‐6 and GM‐CSF as well as of arachidonic acid‐derived cyclooxygenase (COX)‐mediated pro‐inflammatory prostaglandins (PGs) and thromboxanes (TXs), hallmarks of strong MC activation. Collectively, these data show that co‐sensing of ATP and IL‐33 results in hyperactivation of MCs, which resembles to MC activation induced by IgE‐mediated crosslinking of the FcεRI. Therefore, the IL‐33/IL‐33R and/or the ATP/P2X7 signalling axis are attractive targets for therapeutical intervention of diseases associated with the loss of integrity of cellular barriers such as allergic and infectious respiratory reactions.

1 September 2015 in Oncotarget
Verified
Journal Article
Open access
PDF file
SDSebastian Drube
Sebastian Drube
FWFranziska Weber
Franziska Weber
CGChristiane Göpfert
Christiane Göpfert
RLRomy Loschinski
Romy Loschinski
MRMandy Rothe
Mandy Rothe
TKThomas Kamradt
Thomas Kamradt
// <![CDATA[ $('.header-date').hide();$('#titleAuthors').hide();$('#abstractHeader').hide(); // ]]> Sebastian Drube1, *, Franziska Weber1, *, Christiane Göpfert1, Romy Loschinski1, Mandy Rothe1, Franziska Boelke1, Michaela A. Diamanti2, Tobias Löhn1, Julia Ruth1, Dagmar Schütz3, Norman Häfner4, Florian R. Greten2, Ralf Stumm3, Karin Hartmann5, Oliver H. Krämer6, Anne Dudeck7, Thomas Kamradt1 1Institut für Immunologie, Universitätsklinikum Jena, Jena, Germany 2Georg-Speyer-Haus, Institute for Tumorbiology and Experimental Therapy, Frankfurt, Germany 3Institut für Pharmakologie, Universitätsklinikum Jena, Jena, Germany 4Gynäkologische Molekularbiologie, Klinik für Frauenheilkunde und Geburtshilfe, Jena, Germany 5Klinik und Poliklinik für Dermatologie und Venerologie, Universität zu Köln, Köln, Germany 6Institut für Toxikologie, Universitätsmedizin Mainz, Mainz, Germany 7Institute for Immunology, Technische Universität Dresden, Medical Faculty Carl Gustav Carus, Dresden, Germany *These authors have contributed equally to this work Correspondence to: Sebastian Drube, e-mail: Sebastian.Drube@med.uni-jena.de Keywords: mast cells, TAK1-IKK2 activation, c-Kit-Lyn-TAK1-IKK2 complex, mitogenic signaling, NF-κB-activation Received: July 01, 2015 Accepted: August 20, 2015 Published: September 01, 2015 ABSTRACT NF-κB activation depends on the IKK complex consisting of the catalytically active IKK1 and 2 subunits and the scaffold protein NEMO. Hitherto, IKK2 activation has always been associated with IκBα degradation, NF-κB activation, and cytokine production. In contrast, we found that in SCF-stimulated primary bone marrow-derived mast cells (BMMCs), IKK2 is alternatively activated. Mechanistically, activated TAK1 mediates the association between c-Kit and IKK2 and therefore facilitates the Lyn-dependent IKK2 activation which suffices to mediate mitogenic signaling but, surprisingly, does not result in NF-κB activation. Moreover, the c-Kit-mediated and Lyn-dependent IKK2 activation is targeted by MyD88-dependent pathways leading to enhanced IKK2 activation and therefore to potentiated effector functions. In neoplastic cells, expressing constitutively active c-Kit mutants, activated TAK1 and IKKs do also not induce NF-κB activation but mediate uncontrolled proliferation, resistance to apoptosis and enables IL-33 to mediate c-Kit-dependent signaling. Together, we identified the formation of the c-Kit-Lyn-TAK1 signalosome which mediates IKK2 activation. Unexpectedly, this IKK activation is uncoupled from the NF-κB-machinery but is critical to modulate functional cell responses in primary-, and mediates uncontrolled proliferation and survival of tumor-mast cells. Therefore, targeting TAK1 and IKKs might be a novel approach to treat c-Kit-driven diseases.

15 October 2017 in The Journal of Immunology
Verified
Journal Article
Open access
PDF file
SDSebastian Drube
Sebastian Drube
RGRandy Grimlowski
Randy Grimlowski
CDCarsten Deppermann
Carsten Deppermann
JFJulia Fröbel
Julia Fröbel
FKFlorian Kraft
Florian Kraft
TKThomas Kamradt
Thomas Kamradt
The neurobeachin-like 2 protein (Nbeal2) belongs to the family of beige and Chediak–Higashi (BEACH) domain proteins. Loss-of-function mutations in the human NBEAL2 gene or Nbeal2 deficiency in mice cause gray platelet syndrome, a bleeding disorder characterized by macrothrombocytopenia, splenomegaly, and paucity of α-granules in megakaryocytes and platelets. We found that in mast cells, Nbeal2 regulates the activation of the Shp1-STAT5 signaling axis and the composition of the c-Kit/STAT signalosome. Furthermore, Nbeal2 mediates granule formation and restricts the expression of the transcription factors, IRF8, GATA2, and MITF as well as of the cell-cycle inhibitor p27, which are essential for mast cell differentiation, proliferation, and cytokine production. These data demonstrate the relevance of Nbeal2 in mast cells above and beyond granule biosynthesis.